Back
Aprea Therapeutics Stock Predictions
The Tech Disruption Wall Street Isn't Talking About...Yet
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
30
APRE
Aprea Therapeutics
Last Price:
2.60
Seasonality Move:
-39.53%
7 Day Trial
ALL ACCESS PASS
$
7
Forget Bitcoin - This Is the Real Opportunity of 2024
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Aprea Therapeutics Stock Forecast
-
Is Aprea Therapeutics Stock Undervalued?
The current Aprea Therapeutics [APRE] share price is $2.60. The Score for APRE is 30, which is 40% below its historic median score of 50, and infers higher risk than normal. - APRE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will Aprea Therapeutics Stock Go Up Next Year?
Data Unavailable
Aprea Therapeutics Stock Rating
Data Unavailable
Aprea Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
aprea.com
52-Week Data
52-Week High:
8.85
52-Week Low:
2.25
Prediction Charts
Market Cap:
14.12M
Price in USD:
2.60
Volume:
13.9K
Beta:
1.05
Technical Analysis
SMA50:
3.31
SMA100:
3.86
SMA200:
4.86
52-Wk Change:
-46%
Stock Predictions
-
Is Aprea Therapeutics stock public?
Yes, Aprea Therapeutics is a publicly traded company. -
What is the Aprea Therapeutics stock quote today?
The Aprea Therapeutics stock price is 2.60 USD today. -
How to buy Aprea Therapeutics stock online?
You can buy Aprea Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Sep-17 | 3.11 | 3.01 | 3.20 | 2.90 |
| Sep-18 | 3.07 | 2.86 | 3.07 | 2.86 |
| Sep-19 | 2.95 | 2.92 | 2.95 | 2.92 |
| Sep-20 | 2.99 | 3.13 | 3.13 | 2.93 |
| Sep-23 | 3.15 | 3.06 | 3.19 | 3.05 |
| Sep-24 | 3.15 | 2.98 | 3.15 | 2.97 |
| Sep-25 | 2.99 | 2.87 | 3.00 | 2.25 |
| Sep-26 | 2.81 | 2.92 | 2.95 | 2.80 |
| Sep-27 | 2.95 | 2.75 | 2.95 | 2.73 |
| Sep-30 | 2.81 | 2.75 | 2.85 | 2.60 |
| Oct-1 | 2.71 | 2.60 | 2.80 | 2.54 |
| Oct-2 | 2.62 | 2.71 | 2.71 | 2.60 |
| Oct-3 | 2.69 | 2.67 | 2.69 | 2.55 |
| Oct-4 | 2.68 | 2.60 | 2.69 | 2.60 |
Aprea Therapeutics Earnings
Data Unavailable
Aprea Therapeutics Forecast Revenue Growth
Data Unavailable
- Analysts estimate an earnings increase this quarter of $0.69 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.21 per share, and an increase next year of $2.56 per share.
* Aprea Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.